05 Feb 2025
// PR NEWSWIRE
24 Jan 2025
// PR NEWSWIRE
18 Nov 2024
// PR NEWSWIRE
Latest Content by PharmaCompass
Reset all filters
01 2ACITRETIN
02 1BEZAFIBRATE
Reset all filters
01 2CAPSULE
02 1TABLET (EXTENDED-RELEASE)
Reset all filters
01 110MG
02 125MG
03 1400MG
Reset all filters
01 1BEZALIP SR
02 2SORIATANE
Regulatory Info :
Registration Country : Canada
Dosage Form : CAPSULE
Dosage Strength : 25MG
Packaging : 30
Brand Name : SORIATANE
Approval Date :
Application Number : 2070863
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Dosage Form : CAPSULE
Dosage Strength : 10MG
Packaging : 30
Brand Name : SORIATANE
Approval Date :
Application Number : 2070847
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Dosage Form : TABLET (EXTENDED-RELEASE)
Dosage Strength : 400MG
Packaging : 30
Brand Name : BEZALIP SR
Approval Date :
Application Number : 2083523
Regulatory Info :
Registration Country : Canada